本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Vor Biopharma Inc.

0.6780
-0.0084-1.22%
成交量:45.19万
成交额:30.36万
市值:8,464.93万
市盈率:-0.40
高:0.7400
开:0.7077
低:0.6371
收:0.6864
数据加载中...
2024/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/28

重要事件披露

Form 8-K - Current report
2024/05/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/02

重要事件披露

Form 8-K - Current report
2024/03/21

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/20

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/06

重要事件披露

Form 8-K - Current report
2023/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/02

重要事件披露

Form 8-K - Current report
2023/08/30

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/12

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/06/09

重要事件披露

Form 8-K - Current report
2023/05/27

重要事件披露

Form 8-K - Current report
2023/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/14

重要事件披露

8-K - Current report
2023/03/23

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/23

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans